Verastem
(NASDAQ) VSTM
Verastem Financials at a Glance
Market Cap
$447.08M
Revenue (TTM)
$30.91M
Net Income (TTM)
$209.47M
EPS (TTM)
$-3.33
P/E Ratio
-1.53
Dividend
$0.00
Beta (Volatility)
1.43 (Average)
Dividend
$0.00
Beta (Volatility)
1.43 (Average)
Price
$5.07
Volume
116,567
Open
$5.05
Price
$5.07
Volume
116,567
Open
$5.05
Previous Close
$5.07
Daily Range
$4.98 - $5.22
52-Week Range
$4.01 - $11.24
Dividend
$0.00
Beta (Volatility)
1.43 (Average)
Price
$5.07
Volume
116,567
Open
$5.05
Previous Close
$5.07
Daily Range
$4.98 - $5.22
52-Week Range
$4.01 - $11.24
VSTM News
Why Verastem Stock Sank Today
Top Drug Stocks Under $5
VSTM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Verastem
Industry
Biotechnology
Sector
Health CareEmployees
102
CEO
Dan Paterson
Website
www.verastem.comHeadquarters
Needham, MA 02494, US
VSTM Financials
Key Financial Metrics (TTM)
Gross Margin
84%
Operating Margin
-6%
Net Income Margin
-7%
Return on Equity
-1480%
Return on Capital
-98%
Return on Assets
-85%
Earnings Yield
-65.36%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$447.08M
Shares Outstanding
87.84M
Volume
116.57K
Short Interest
0.00%
Avg. Volume
1.88M
Financials (TTM)
Gross Profit
$25.62M
Operating Income
$170.13M
EBITDA
$170.13M
Operating Cash Flow
$137.51M
Capital Expenditure
$0.00
Free Cash Flow
$137.51M
Cash & ST Invst.
$204.99M
Total Debt
$76.86M
Verastem Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$17.54M
N/A
Gross Profit
$14.64M
N/A
Gross Margin
83.51%
N/A
Market Cap
$447.08M
N/A
Market Cap/Employee
$5.73M
N/A
Employees
78
N/A
Net Income
$32.92M
+49.0%
EBITDA
$41.18M
+34.9%
Quarterly Fundamentals
Net Cash
$117.82M
+153.0%
Accounts Receivable
$8.81M
+4306.5%
Inventory
$1.83M
N/A
Long Term Debt
$81.33M
+97.1%
Short Term Debt
$5.84M
+486.8%
Return on Assets
-85.00%
N/A
Return on Invested Capital
-97.68%
N/A
Free Cash Flow
$29.95M
-19.3%
Operating Cash Flow
$29.95M
-19.3%